Bausch & Lomb deal refuses to die
Advanced Medical Optics Inc. proposed two ways to demonstrate that its shareholders would support an offer to buy competing eye-care product maker Bausch & Lomb Inc. for $4.3 billion, after the second-largest investor balked.
Advanced Medical is prepared to discuss the proposal with its main shareholders contingent on Bausch & Lomb’s waiving a confidentiality deal, according to a letter to a committee of Bausch & Lomb’s board.
The letter was a response to one earlier this week from Rochester, N.Y.-based Bausch & Lomb asking for evidence that Advanced Medical’s stockholders would support the takeover.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
